Literature DB >> 34492402

Nonrespiratory Comorbidities in Asthma.

Juan Carlos Cardet1, Adeeb A Bulkhi2, Richard F Lockey3.   

Abstract

Asthma is a chronic heterogeneous airway disease. Common comorbid conditions are often disproportionately present in severe asthma. Optimal care of patients with asthma requires the recognition and treatment of these comorbid conditions. This review outlines the pathophysiological mechanisms between nonrespiratory comorbid conditions and asthma and their effect on asthma outcomes. They include: type 2 diabetes mellitus, hypertension, atherosclerotic cardiovascular disease, adrenal and thyroid gland diseases, pregnancy, osteoporosis, adverse effects from medications, and mental health disorders. Studies indicate how poor glycemic control of type 2 diabetes mellitus is associated with not only greater health care utilization but poorer asthma outcomes. Also, a large health care claims database indicates that a substantial proportion of pregnant women have uncontrolled asthma and are prescribed suboptimal controller therapy. Additional data about these nonrespiratory comorbidities and medications known to benefit both nonrespiratory comorbidities and asthma are necessary.
Copyright © 2021 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adrenal disease; Adverse effects from medications; Airway hyperresponsiveness; Asthma; Atherosclerotic cardiovascular disease; Insulin resistance; Mental health disorders; Osteoporosis; Pregnancy; Thyroid disease

Mesh:

Year:  2021        PMID: 34492402      PMCID: PMC8631133          DOI: 10.1016/j.jaip.2021.08.027

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


  133 in total

Review 1.  Adrenal Insufficiency in Corticosteroids Use: Systematic Review and Meta-Analysis.

Authors:  Leonie H A Broersen; Alberto M Pereira; Jens Otto L Jørgensen; Olaf M Dekkers
Journal:  J Clin Endocrinol Metab       Date:  2015-04-06       Impact factor: 5.958

2.  Insulin and insulin-like growth factor-1 receptors act as ligand-specific amplitude modulators of a common pathway regulating gene transcription.

Authors:  Jeremie Boucher; Yu-Hua Tseng; C Ronald Kahn
Journal:  J Biol Chem       Date:  2010-04-01       Impact factor: 5.157

3.  Factors Associated with Dysfunctional Breathing in Patients with Difficult to Treat Asthma.

Authors:  Eve Denton; Janet Bondarenko; TunnRen Tay; Joy Lee; Naghmeh Radhakrishna; Fiona Hore-Lacy; Catherine Martin; Ryan Hoy; Robyn O'Hehir; Eli Dabscheck; Mark Hew
Journal:  J Allergy Clin Immunol Pract       Date:  2018-12-07

4.  IL-6 is required for airway mucus production induced by inhaled fungal allergens.

Authors:  Wendy A Neveu; Jenna B Allard; Oliver Dienz; Matthew J Wargo; Gennaro Ciliberto; Laurie A Whittaker; Mercedes Rincon
Journal:  J Immunol       Date:  2009-07-10       Impact factor: 5.422

5.  Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide.

Authors:  Sylvie Lemonde; Gustavo Turecki; David Bakish; Lisheng Du; Pavel D Hrdina; Christopher D Bown; Adolfo Sequeira; Neena Kushwaha; Stephen J Morris; Ajoy Basak; Xiao-Ming Ou; Paul R Albert
Journal:  J Neurosci       Date:  2003-09-24       Impact factor: 6.167

Review 6.  Glucocorticoid-Induced Osteoporosis: New Insights into the Pathophysiology and Treatments.

Authors:  Nancy E Lane
Journal:  Curr Osteoporos Rep       Date:  2019-02       Impact factor: 5.096

7.  Intrauterine growth is related to gestational pulmonary function in pregnant asthmatic women. Kaiser-Permanente Asthma and Pregnancy Study Group.

Authors:  M Schatz; R S Zeiger; C P Hoffman
Journal:  Chest       Date:  1990-08       Impact factor: 9.410

8.  Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction.

Authors:  Meena S Madhur; Heinrich E Lob; Louise A McCann; Yoichiro Iwakura; Yelena Blinder; Tomasz J Guzik; David G Harrison
Journal:  Hypertension       Date:  2009-12-28       Impact factor: 10.190

9.  Statins for asthma.

Authors:  Cho Naing; Han Ni
Journal:  Cochrane Database Syst Rev       Date:  2020-07-15

10.  KIT Inhibition by Imatinib in Patients with Severe Refractory Asthma.

Authors:  Katherine N Cahill; Howard R Katz; Jing Cui; Juying Lai; Shamsah Kazani; Allison Crosby-Thompson; Denise Garofalo; Mario Castro; Nizar Jarjour; Emily DiMango; Serpil Erzurum; Jennifer L Trevor; Kartik Shenoy; Vernon M Chinchilli; Michael E Wechsler; Tanya M Laidlaw; Joshua A Boyce; Elliot Israel
Journal:  N Engl J Med       Date:  2017-05-18       Impact factor: 91.245

View more
  1 in total

1.  Increased Risk of Hypothyroidism in People with Asthma: Evidence from a Real-World Population-Based Study.

Authors:  Shih-Cheng Huang; Shuo-Yan Gau; Jing-Yang Huang; Wen-Jun Wu; James Cheng-Chung Wei
Journal:  J Clin Med       Date:  2022-05-14       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.